Alcon AG | ALC - Gross Profit On Sales


Alcon AG reported $1.69B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AstraZeneca USD 12.86B 251M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Essilor EUR 9.41B 1.12B Jun/2026
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.18B 210M Mar/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GRIFOLS EUR 704M 84M Jun/2026
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Philips EUR 2.15B 384M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
Smith & Nephew USD 2.09B 117M Dec/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
UCB EUR 3.19B 621M Dec/2025